Dysport abobotulinumtoxinA: Additional Phase III data

Additional data from a double-blind, international Phase III trial in 241 children ages 2-17 with dynamic equinus foot deformity due to cerebral palsy showed that the 15

Read the full 270 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE